(We use semaglutide 2.4 mg to describe the drug marketed as Wegovy independent of dose to distinguish it from other brands of semaglutide-containing products [i.e., Ozempic, Rybelsus] that have different indications and/or routes of administration.) Clinical trials in the Semaglutide Treatment Effect in People with Obesity (STEP) program have demonstrated the efficacy of semaglutide 2.4 mg in reducing weight in adults with obesity and overweight [9]

4.4 Weight Loss Results / Efficacy Average weight loss of 7.6% with Orlistat 8 versus ~2.0% with placebo at 24 months Over 2 years, 57% of Orlistat users maintained 5% weight loss , versus 9 37.4% in placebo recipients 4.5 Post-GLP1 Use Case 4.5 Post-GLP1 Use Case Direct studies pairing Orlistat with GLP1 tapering are limited, but emerging real-world evidence and pharmacology suggest it can help maintain weight loss: In many patients who transitioned off GLP1 therapy, Orlistat aided in preventing weight regain by continuing fat-blocking effects despite reduced appetite suppression
Over-the-counter remedies like loperamide provide relief for acute episodes
We can have a nuanced conversation with the patient about taking the medication, what the benefits are, what the potential risks are, and help them formulate a plan to transition off the medication once theyre ready to start trying to conceive, she says
By mimicking the actions of the natural GLP-1 hormone, semaglutide helps the body release insulin, slows digestion, and controls blood sugar levels after meals
It's designed for people in Stockbridge, Georgia, and beyond who seek a tirzepatide-like effect in pill form, though it utilizes semaglutide instead of tirzepatide